Anyone know more about this??? Is this our answer?

Options

Comments

  • zarovka
    zarovka Member Posts: 3,607
    edited August 2016

    Thanks for posting this. It looks like they are researching another avenue for targeting characteristics that are unique to cancer cells.

    This is this the original article about the discovery from 2012. It has taken them 4 years to form a company to license and develop this technology for clinical trials. The clinical trials, if they get there, will start at the earliest in 2017. The clinical trial process takes 5-7 years to get to a result. It takes 10's of these efforts to produce one effective treatment.

    Fortunately there are many many efforts like this one. I don't know if this is it, but I am hopeful about where we are headed. People would not be so surprised at the cost of effective treatments like Ibrance if they really thought about how many failures it takes to get one success. The reward for an effective treatment has to be pretty high in order to drive this system.

    >Z<

  • Lindalou
    Lindalou Member Posts: 647
    edited August 2016

    It's always interesting to read about new research and possible treatment for us. However, as Z noted this all takes time to come to a pre-clinical trial and then a clinical trial which would only be phase 1. FDA approval of a phase 1 trial is often slow and lengthy as efficacy etc is determined. However, having just said that, any effort in discovering new therapies for metastatic disease is hopeful, and perhaps Dr. Khaled's research could be a future treatment indeed. Having a sponsoring biotech firm that has nanotechnology experience is a promising step.

  • keetmom
    keetmom Member Posts: 432
    edited August 2016

    It is good to see there is stuff like this though and it says clinical trials could be late next year...

Categories